Research Topics
Species | B F GageSummaryAffiliation: Washington University School of Medicine Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarinBrian F Gage
Department of Medicine, Washington University School of Medicine Campus Box 8005, 660 S Euclid Ave St Louis, Missouri 63110, USA
Thromb Haemost 91:87-94. 2004..001). In conclusion, the maintenance warfarin dose can be estimated from demographic, clinical, and pharmacogenetic factors that can be obtained at the time of warfarin initiation...
Pharmacogenetics and anticoagulant therapyBrian F Gage
Division of General Medical Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
J Thromb Thrombolysis 16:73-8. 2003..Thus, a comprehensive dosing algorithm offers the most promising approach to estimating the therapeutic dose of warfarin a priori and to preventing hemorrhage during warfarin induction...
Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fallBrian F Gage
Division of General Medical Sciences, Washington University School of Medicine, St Louis, MO, USA
Am J Med 118:612-7. 2005..Patients at high risk for falls are presumed to be at increased risk for intracranial hemorrhage, and high risk for falls is cited as a contraindication to antithrombotic therapy. Data substantiating this concern are lacking...
Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplementsBrian F Gage
Division of General Medical Sciences, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid, St. Louis, MO 63110, USA
Thromb Res 117:55-9; discussion 65-7. 2005
Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2Brian F Gage
Division of General Medical Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
Arch Intern Med 166:241-6. 2006..Vitamin K antagonists such as warfarin inhibit this process. Our goal was to quantify the association between warfarin and osteoporotic fractures in patients with atrial fibrillation...
Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)Brian F Gage
Division of General Medical Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
Am Heart J 151:713-9. 2006..Our objective was to find a bleeding classification scheme that could quantify the risk of hemorrhage in elderly patients with atrial fibrillation...
Pharmacogenetics of warfarin: regulatory, scientific, and clinical issuesBrian F Gage
Washington University Medical Center, St Louis, MO 63110, USA
J Thromb Thrombolysis 25:45-51. 2008..The FDA completed the label update in August 2007...
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarinB F Gage
Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri, USA
Clin Pharmacol Ther 84:326-31. 2008..To facilitate use of these pharmacogenetic and clinical algorithms, we developed a nonprofit website, http://www.WarfarinDosing.org...
Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirinBrian F Gage
Division of General Medical Sciences, Washington University School of Medicine Campus Box 8005, 660 S Euclid Ave, St Louis, MO 63110, USA
Circulation 110:2287-92. 2004..This prospective cohort study tested the predictive accuracy of 5 stroke risk stratification schemes...
Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillationShimoli V Shah
Department of Medicine, Washington University School of Medicine, Campus Box 8005, 660 S Euclid Ave, St Louis, MO 63110, USA
Circulation 123:2562-70. 2011..Recent studies have investigated alternatives to warfarin for stroke prophylaxis in patients with atrial fibrillation (AF), but whether these alternatives are cost-effective is unknown...
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial FibrillationB F Gage
Division of General Medical Sciences, Washington University School of Medicine Campus, Box 8005, 660 S Euclid Ave, St Louis, MO 63110, USA
JAMA 285:2864-70. 2001..Patients who have atrial fibrillation (AF) have an increased risk of stroke, but their absolute rate of stroke depends on age and comorbid conditions...
Warfarin therapy for an octogenarian who has atrial fibrillationB F Gage
Division of General Medical Science, Washington University School of Medicine, Campus Box 8005, 660 South Euclid Avenue, St Louis, MO 63110, USA
Ann Intern Med 134:465-74. 2001..Finally, when the patient develops dental pain, we review the analgesic agents that are safe to take with warfarin and explain why warfarin therapy does not have to be interrupted during a subsequent dental extraction...
Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapyN S Ferder
Saint Louis College of Pharmacy, St Louis, MO, USA
J Thromb Haemost 8:95-100. 2010..Experts have hypothesized that genotype becomes irrelevant once international normalized ratio (INR) values are available because INR response reflects warfarin sensitivity...
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African AmericansD Voora
Department of Medicine, Washington University in St Louis, St Louis, Missouri, USA
Clin Pharmacol Ther 87:445-51. 2010..14, one-sided P = 0.03). CALU rs339097 A>G is associated with higher warfarin dose requirements, independent of known genetic and nongenetic predictors of warfarin dose in African Americans...
Integration of genetic, clinical, and INR data to refine warfarin dosingP Lenzini
Department of Internal Medicine, Washington University, St Louis, Missouri, USA
Clin Pharmacol Ther 87:572-8. 2010..002). After several days of therapy, a pharmacogenetic algorithm estimates the therapeutic warfarin dose more accurately than one using clinical factors and INR response alone...
Patient and physician satisfaction with a telephone-based anticoagulation serviceA D Waterman
Division of General Medical Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
J Gen Intern Med 16:460-3. 2001..To compare the satisfaction and knowledge of patients who have their warfarin managed by their physician or by a multidisciplinary, telephone-based anticoagulation service (ACS) and to assess referring physicians' satisfaction with the ACS...
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotypeDeepak Voora
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Thromb Haemost 93:700-5. 2005..Prospective, perioperative pharmacogenetics-based dosing of warfarin is feasible; however, further evaluation in a randomized, controlled study is recommended...
Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study designE J Do
Department of Internal Medicine, Washington University, St Louis, MO, USA
Pharmacogenomics J 12:417-24. 2012....
Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillationB F Gage
Division of General Medical Sciences, Washington University, St Louis, MO, USA
Stroke 29:1083-91. 1998..The preference-based strategy prescribed whichever antithrombotic therapy, warfarin or aspirin, had the greater projected quality-adjusted survival...
Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillationElena Birman-Deych
Washington University School of Medicine, St. Louis, MO 63110, USA
Stroke 37:1070-4. 2006..048). CONCLUSIONS: The use, monitoring, and effectiveness of warfarin therapy are suboptimal in Medicare beneficiaries, especially in black and Hispanic beneficiaries...
Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patientsP A Lenzini
Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
J Thromb Haemost 6:1655-62. 2008..Warfarin is commonly prescribed for prophylaxis and treatment of thromboembolism after orthopedic surgery. During warfarin initiation, out-of-range International Normalized Ratio (INR) values and adverse events are common...
The pharmacogenetics of coumarin therapyDeepak Voora
Washington University School of Medicine, Departments of Medicine and of Pathology, St. Louis, MO 63110, USA
Pharmacogenomics 6:503-13. 2005..A comprehensive pharmacogenetics approach to warfarin therapy has the potential to improve the safety and efficiency of warfarin initiation...
Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin doseCristi R King
Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Am J Clin Pathol 129:876-83. 2008..Current commercial platforms provide accurate and rapid genotypes for pharmacogenetic dosing during initiation of warfarin therapy...
Comorbidity indices to predict mortality from Medicare data: results from the national registry of atrial fibrillationYan Yan
Division of General Medical Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA
Med Care 43:1073-7. 2005..CONCLUSION: The predictive accuracy of 3 administrative-data based indices was similar and comparable with chart-review...
Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillationB F Gage
Division of General Medical Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
Stroke 31:822-7. 2000....
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding ScoreSumeet Subherwal
Cardiovascular Division, Washington University School of Medicine, St Louis, MO 63110, USA
Circulation 119:1873-82. 2009..Baseline prediction of bleeding risk can complement ischemic risk prediction for optimization of NSTEMI care; however, existing models are not well suited for this purpose...
Optimal initial dose adjustment of warfarin in orthopedic patientsPetra A Lenzini
Washington University in St Louis, St Louis, MO 63110, USA
Ann Pharmacother 41:1798-804. 2007..Dosing algorithms have not been widely adopted because they require a fixed initial warfarin dose (eg, 5 mg) and are not tailored to other factors that may affect the international normalized ratio (INR)...
Substitution of generic warfarin for Coumadin in an HMO settingPaul E Milligan
Division of General Medical Sciences, Barnes-Jewish Hospital Blood Thinner Clinic, School of Medicine, Washington University, 660 S. Euclid Avenue, St. Louis, MO 63110-1093, USA
Ann Pharmacother 36:764-8. 2002..Our findings suggest that HMOs can safely substitute at least 1 generic formulation of warfarin without extra monitoring...
Genetic-based dosing in orthopedic patients beginning warfarin therapyEric A Millican
Department of Medicine, Washington University in St Louis, MO 63110, USA
Blood 110:1511-5. 2007..If validated, this model should provide a safer, more effective process for initiating warfarin therapy...
Risk of stroke after surgery in patients with and without chronic atrial fibrillationS Kaatz
Department of Medicine, Henry Ford Hospital, Detroit, MI 48202, USA
J Thromb Haemost 8:884-90. 2010..The extent to which chronic atrial fibrillation affects the risk of postoperative stroke is largely unknown...
Establishing and running an effective telephone-based anticoagulation serviceA D Waterman
Division of General Medical Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
J Vasc Nurs 19:126-32; quiz 133-4. 2001....
The impact of the introduction of a rapid D-dimer assay on the diagnostic evaluation of suspected pulmonary embolismN M Goldstein
Campus Box 8052, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110, USA
Arch Intern Med 161:567-71. 2001..Although this hypothesis is anticipated to decrease the use of ventilation-perfusion (VQ) scans and other diagnostic tests for PE, it has not been tested in a "real-world" environment...
Outpatient treatment of acute venous thromboembolic diseaseRoger D Yusen
Division of Pulmonary and Critical Care Medicine, Division of General Medical Sciences, Washington University School of Medicine, Barnes Jewish Hospital, 660 South Euclid Avenue, St Louis, MO 63110, USA
Clin Chest Med 24:49-61. 2003..Explicit criteria exist for outpatient DVT therapy. Home therapy for PE requires further evaluation before it can be recommended outside of a trial or other supervised setting...
Reliability for grading acute rejection and airway inflammation after lung transplantationMurali M Chakinala
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Heart Lung Transplant 24:652-7. 2005..This investigation assessed the reliability of the current LRSG system by determining inter- and intrareader agreement for grading transbronchial biopsy samples from lung transplant recipients...
Use of pharmacogenetics to guide warfarin therapyDeepak Voora
Departments of Medicine and Pathology, Washington University School of Medicine, St Louis, Missouri 63110, USA
Drugs Today (Barc) 40:247-57. 2004..The genotype assays for genetic variants relevant to warfarin are widely used and are being developed for commercial use (5), making the promise of a pharmacogenetics-based approach a near reality...
Anemia: an independent predictor of death and hospitalizations among elderly patients with atrial fibrillationShivak Sharma
Washington University in St Louis School of Medicine Barnes Jewish Hospital, St Louis, MO, USA
Am Heart J 157:1057-63. 2009..Anemia is an independent predictor of mortality and morbidity for numerous cardiovascular and noncardiovascular diseases, but the association of anemia with mortality and hospitalizations in patients with AF requires clarification...
Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factorsElena Birman-Deych
Division of General Medical Sciences, Washington University School of Medicine, St. Louis, Missouri 63110, USA
Med Care 43:480-5. 2005..Where feasible, review of additional data (eg, physician notes or imaging studies) should be used to confirm the diagnosis of valvular disease, arterial peripheral embolus, intracranial hemorrhage, and deep venous thrombosis...
Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillationBrian F Gage
Washington University School of Medicine, St Louis, MO 63110, USA
JAMA 293:699-706. 2005....
Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantationMurali M Chakinala
Division of Pulmonary and Critical Care Medicine, Saint Louis, Missouri 63110, USA
J Heart Lung Transplant 23:1396-404. 2004....
Effect of warfarin nonadherence on control of the International Normalized RatioAmy D Waterman
Division of General Medical Sciences, School of Medicine, Washington University, Campus Box 8005, 660 S Euclid, St Louis, MO 63110, USA
Am J Health Syst Pharm 61:1258-64. 2004..The frequency and causes of ab- errant International Normalized Ratios (INRs) in warfarin recipients and the percentage explainable by warfarin nonadherence were studied...
An invasive strategy is associated with decreased mortality in patients 80 years and older with acute myocardial infarctionTimothy W Schloss
Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Am J Geriatr Cardiol 16:84-91. 2007..These data suggest that in patients 80 years and older who are hospitalized with acute myocardial infarction, an invasive strategy confers a significant survival advantage during the first year after hospital discharge...
Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratioGerald A Banet
Division of General Medical Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA
Chest 123:499-503. 2003..3, and reducing the dose for patients who have a greater INR or an increased risk of hemorrhage. Warfarin dose reductions > 20% should be avoided for mildly elevated INRs...
Implantable cardioverter-defibrillator therapy improves long-term survival in patients with unexplained syncope, cardiomyopathy, and a negative electrophysiologic studyJosé Mauricio Sánchez
Cardiovascular Division, Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
Heart Rhythm 2:367-73. 2005..The purpose of this study was to evaluate the long-term outcomes of patients with unexplained syncope, ischemic or nonischemic cardiomyopathy, and a negative electrophysiologic study (EPS)...
Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failureWilliam T Katsiyiannis
Cardiovascular Division, Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri
Am J Cardiol 95:286-8. 2005..Reduced SPP reserve identified patients who are at high risk for experiencing progressive HF...
Cost-savings analysis of using a portable coagulometer for monitoring homebound elderly patients taking warfarinDorothy S Cheung
Division of General Medical Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA
Am J Geriatr Cardiol 12:283-7. 2003..The cost savings and potential improvement in quality of care argue for equipping home health nurses with portable coagulometers...
Risk factors for bleeding in patients taking coumarinsRebecca J Beyth
Division of General Medical Sciences, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid Avenue, St. Louis, MO 63110, USA
Curr Hematol Rep 1:41-9. 2002..During ongoing therapy with coumarins, the risks and benefits of therapy should be reassessed periodically. This article reviews the current evidence for the prediction and prevention of coumarin-related bleeding...
Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fractionRoger Kerzner
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Am Heart J 146:286-90. 2003..Traditional predictors of mortality in patients with reduced LVEF may not apply to elderly patients with preserved LVEF...
Use of EPO in critically ill patients with acute renal failure requiring renal replacement therapyJeanie Park
Division of General Medical Sciences, Department of Internal Medicine, Washington University, St Louis, MO 63110, USA
Am J Kidney Dis 46:791-8. 2005..A randomized controlled trial is needed to evaluate the potential benefits of EPO use in patients with ARF...
Criteria for outpatient management of proximal lower extremity deep venous thrombosisR D Yusen
Department of Medicine, Barnes Jewish Hospital, Washington University School of Medicine, St Louis, MO 63110, USA
Chest 115:972-9. 1999..To develop and to evaluate selection criteria for outpatient management of deep venous thrombosis (DVT)...
Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplantEugene F Yen
Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA
Am J Transplant 4:1703-8. 2004..Extended Medicare immunosuppression coverage to the life of a kidney transplant should result in better transplant and economic outcomes, and should be considered by policy makers...
Anemia does not predict mortality in elderly patients with heart failureRoger Kerzner
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Am J Geriatr Cardiol 16:92-6. 2007..The authors conclude that anemia is not an important predictor of long-term survival in very elderly patients hospitalized with HF...
The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysisLauren B Gerson
Division of Gastroenterology, Stanford University School of Medicine, California 94305 5202, USA
Am J Med 116:451-9. 2004..The management of patients who undergo endoscopy while being treated with warfarin is challenging. We used decision analysis to determine the preferred strategy to manage anticoagulants in the periendoscopic period...
Randomized trial of warfarin nomogramsBrian F Gage
Ann Intern Med 140:489; author reply 491-2. 2004
Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision makingMalcolm Man-Son-Hing
Elisabeth Bruyere Research Institute and Division of Geriatric Medicine, University of Ottawa, Ottawa, Ontario, Canada
Med Decis Making 25:548-59. 2005..The authors compared the thresholds for antithrombotic treatment from studies that determined or modeled the treatment preferences of patients with atrial fibrillation with recommendations from clinical practice guidelines...
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin doseMark J Rieder
Department of Genome Sciences, University of Washington, Seattle, USA
N Engl J Med 352:2285-93. 2005..The management of warfarin therapy is complicated by a wide variation among patients in drug response. Variants in the gene encoding vitamin K epoxide reductase complex 1 (VKORC1) may affect the response to warfarin...
Perioperative reduction of the warfarin dosePaul E Milligan
Am J Med 115:741-2. 2003
CYP4F2 genetic variant alters required warfarin doseMichael D Caldwell
Department of Surgery, Marshfield Clinic, Marshfield, WI, USA
Blood 111:4106-12. 2008..Genetic variation of CYP4F2 was associated with a clinically relevant effect on warfarin requirement...
Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?Lawrence Baruch
Bronx VA Hospital, Bronx, NY 10468, USA
Stroke 38:2459-63. 2007..The objective of this study was to assess the predictive value of stroke risk classification schemes and to identify patients with atrial fibrillation who are at substantial risk of stroke despite optimal anticoagulant therapy...
Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillationRobert G Hart
Stroke 39:1901-10. 2008..Additional research to identify an optimum scheme for primary prevention and subsequent standardization of recommendations may lead to more uniform selection of patients for anticoagulant prophylaxsis...
Is primary care ready for pharmacogenetics?Deepak Voora
Pharmacogenomics 7:1-3. 2006
Research Grants
- Pharmacogenetics and Antithrombotic TherapyBrian Gage; Fiscal Year: 2003..Using high performance liquid chromatography, we will measure the levels of the 2 enantiomers of warfarin and test Hypothesis 4: Clearance of S-warfarin will be significantly decreased in the presence of 2C9 SNPs. ..
